{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:36:08Z","timestamp":1747157768921,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T00:00:00Z","timestamp":1440633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.clinthera.2015.08.016","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T04:12:05Z","timestamp":1443672725000},"page":"2339-2346","source":"Crossref","is-referenced-by-count":1,"title":["Adherence to Guidelines and the Screening Tool of Older Persons\u2019 Potentially Inappropriate Prescriptions Criteria for Colchicine Dosing for Gout Treatment in Beneficiaries of the Nova Scotia Seniors\u2019 Pharmacare Program"],"prefix":"10.1016","volume":"37","author":[{"given":"Emily","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Sketris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-8846","authenticated-orcid":false,"given":"Chris","family":"Skedgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Hanly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.08.016_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ajkd.2002.33911","article-title":"The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988\u20131994","volume":"40","author":"Kramer","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2015.08.016_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2015.08.016_bib3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clinthera.2015.08.016_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.clinthera.2015.08.016_bib5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthitis Rheum"},{"key":"10.1016\/j.clinthera.2015.08.016_bib6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bmj.327.7426.1275","article-title":"Colchicine in acute gout","volume":"327","author":"Morris","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2015.08.016_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systemic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.clinthera.2015.08.016_bib8","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice. Gout","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2015.08.016_bib9","first-page":"801","article-title":"Gout: an update","volume":"76","author":"Eggebeen","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2015.08.016_bib10","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheum"},{"key":"10.1016\/j.clinthera.2015.08.016_bib11","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2165\/11205470-000000000-00000","article-title":"Oral colchicine (Colcrys) in the treatment and prophylaxis of gout","volume":"70","author":"Yang","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2015.08.016_bib12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2015.08.016_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjopharm.2011.07.004","article-title":"Management of gout in the older adult","volume":"9","author":"Fravel","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.clinthera.2015.08.016_bib14","unstructured":"Highlights of Prescribing Information. Colcrys (colchicine). http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/022351lbl.pdf. Accessed November 17, 2014."},{"key":"10.1016\/j.clinthera.2015.08.016_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening Tool of Older Person\u2019s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation","volume":"46","author":"Gallagher","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2015.08.016_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.clinthera.2015.08.016_bib17","unstructured":"Government of Nova Scotia. Nova Scotia Pharmacare Formulary: Government of Nova Scotia. http:\/\/novascotia.ca\/dhw\/pharmacare\/seniors-pharmacare.asp. Accessed April 30, 2014."},{"key":"10.1016\/j.clinthera.2015.08.016_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.22474","article-title":"Validity of gout diagnosis in administrative data","volume":"57","author":"Harrold","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2015.08.016_bib19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/ard.2006.051649","article-title":"Sex differences in gout epidemiology: evaluation and treatment","volume":"65","author":"Harrold","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2015.08.016_bib20","unstructured":"Health Canada. Drug Product Online Query. 2012. http:\/\/webprod3.hc-sc.gc.ca\/dpd-bdpp\/dispatch-repartition.do?lang=eng. Accessed April 30, 2014."},{"year":"2014","series-title":"RxFiles: Drug Comparison Charts","key":"10.1016\/j.clinthera.2015.08.016_bib21"},{"key":"10.1016\/j.clinthera.2015.08.016_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1445-5994.2010.02165.x","article-title":"Acute gout management during hospitalization: a need for a protocol","volume":"41","author":"Gnanenthiran","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.clinthera.2015.08.016_bib23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/acr.22275","article-title":"Evaluating appropriate use of prophylactic colchicine for gout flare prevention","volume":"66","author":"George","year":"2014","journal-title":"Arthiritis Care Res"},{"key":"10.1016\/j.clinthera.2015.08.016_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1756-185X.2011.01642.x","article-title":"Improved management of acute gout during hospitalization following introduction of a protocol","volume":"15","author":"Kamalaraj","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clinthera.2015.08.016_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2296-11-90","article-title":"Developing a computer delivered, theory based intervention for guideline implementation in general practice","volume":"11","author":"McDermott","year":"2010","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.clinthera.2015.08.016_bib26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/intqhc\/mzt043","article-title":"Information technology interventions to improve medication safety in primary care: a systematic review","volume":"25","author":"Lainer","year":"2013","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.clinthera.2015.08.016_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijmedinf.2013.02.003","article-title":"Design of decision support interventions for medication prescribing","volume":"82","author":"Horsky","year":"2013","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.clinthera.2015.08.016_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.18553\/jmcp.2012.18.8.627","article-title":"Improving the success of mailed letter intervention programs to influence prescribing behaviours: a review","volume":"18","author":"Ho","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinthera.2015.08.016_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","article-title":"The incident user design in comparative effectiveness research","volume":"22","author":"Johnson","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815010723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815010723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T14:11:26Z","timestamp":1653228686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815010723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0149291815010723"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.08.016","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}